About 100 reports

  • NETHERLANDS PHARMACEUTICALS MARKET GEOGRAPHY SEGMENTATION: $ BILLION, 2017
  • NETHERLANDS PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-17

Pharmaceuticals in the Netherlands Summary Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players...

  • Pharmaceutical
  • Netherlands
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • 2 CHEMICAL AND PHARMACEUTICAL PLANTS CONSTRUCTION: CATEGORY DATA
  • 3 CHEMICAL AND PHARMACEUTICAL PLANTS CONSTRUCTION: ACTIVITY ANALYSIS

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in the Netherlands to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

  • Construction
  • Pharmaceutical
  • Netherlands
  • Market Size
  • Supply
  • 2.1 Overall Chemical and Pharmaceutical Plants construction Output
  • Timetric- Chemical and Pharmaceutical Plants construction Market Definitions

Synopsis Timetric’s "Chemical and Pharmaceutical Plants (Construction) in Netherlands: Market Analytics by Category & Cost Type to 2021" contains historic and forecast market data for the chemical and pharmaceutical plants category in Netherlands, it also provides detailed breakdown of the data by construction activity (new construction,...

  • Construction
  • Pharmaceutical
  • Netherlands
  • Market Size
  • Supply
  • OMEGA PHARMA NEDERLAND BV
  • Omega Pharma Nederland BV: Key Facts

Perrigo completed the acquisition of Omega Pharma NV in March 2015. Perrigo has started to expand internationally, and it its strategy is to leverage the combined product portfolio of Perrigo and Omega Pharma by combining Perrigo’s supply chain and operational excellence with Omega’s OTC branding and regulatory expertise. Euromonitor...

  • Pharmaceutical
  • Netherlands
  • Demand
  • Omega
  • Perrigo Company

2018 and Beyond: Netherlands Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Executive Summary ##. ## Netherlands Pharmaceutical and Healthcare Industry Snapshot ##. ## Netherlands

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Demand
  • Market Size
  • Retail Pharmacies
  • Prescribing Controls

Box ##: Information Requirements for Reimbursement Applications Product details (eg brand name, active ingredient, ATC code, pharmaceutical form, strength, pack size).

  • Pharmaceutical
  • Netherlands
  • Market Size
  • Achmea Group
  • Novartis AG
  • REMARK PHARMA BV
  • May 2017

The company is committed to keep investing to build further demand for the portfolio of brands it holds in beauty and personal care products on the Dutch market. The strategy centres on consolidating in categories with stronger brands such as deodorants and bath and shower and considering introducing new ones to strengthen others...

  • Body Care
  • Male Grooming
  • Personal Hygiene
  • Pharmaceutical
  • Netherlands
  • 5.4.8 Pharmaceutical Advertising Regulations
  • PHARMACEUTICAL MARKET, NETHERLANDS, REVENUE ($BN), 2017-2021

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands Summary Pharmaceutical market in the Netherlands was valued at $7.1 Billion in 2009. It declined to $5.8 Billion in 2014 and is expected to further decline to $5.1 Billion in 2017. The decline in value terms has primarily...

  • Pharmaceutical
  • Netherlands
  • Essilor group
  • Medtronic, Inc.
  • Roche Group
  • Teva Pharmaceutical Industries Limited: key facts
  • Teva Pharmaceutical Industries Limited: revenues & profitability

Generics in the Netherlands Summary Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key...

  • Pharmaceutical
  • Netherlands
  • Mylan Inc.
  • Novartis AG
  • Sanofi S.A.
  • REMARK PHARMA BV
  • Summary 2

Remark Pharma BV is a manufacturer and distributor of consumer health brands in the Netherlands. Remark strives to add value by selling local brands via well trusted retailers in the Netherlands, such as the independent retailers, supermarkets and drugstores. The company would like to extend its product range in OTC medicine in the future...

  • Healthcare
  • OTC
  • Pharmaceutical
  • Netherlands
  • Demand
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (EUR Million), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 4.6% to reach US$ 110.1 billion by 2022. The industrial building construction market in value terms is expected to reach US$ 4.5 billion in 2018. This report from ConsTrack360 provides data-centric analyses on industrial construction...

  • Industrial Construction
  • Pharmaceutical
  • Netherlands
  • Forecast
  • Market Size
  • 4 Chemical and Pharmaceutical Plants construction: Market Analysis
  • 4.3 Chemical and Pharmaceutical Plants construction Output, by Cost

Synopsis Timetric’s "Industrial Construction Market in the Netherlands: Market Size, Growth and Forecast Analytics to 2021" contains historic and forecast market data for the industrial construction market in Netherlands, with a detailed breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

  • Construction
  • Pharmaceutical
  • Netherlands
  • Market Size
  • Supply
  • Dutch Chemical and Pharmaceutical Plants Construction, Repair & Maintenance
  • 4 CHEMICAL AND PHARMACEUTICAL PLANTS CONSTRUCTION: CATEGORY DATA

Synopsis Timetric’s 'Industrial Construction in the Netherlands to 2020: Market Forecast' contains detailed historic and forecast market value data for the industrial construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook...

  • Pharmaceutical
  • Netherlands
  • Forecast
  • Market Size
  • Supply
  • Pharmaceutical sales
  • Pharma and biotech

As in other west European countries, population ageing and expensive new technologies are straining the healthcare system in the Netherlands. The Dutch healthcare system is successful in providing wide-spread coverage, but it is struggling to contain cost growth. According to the Centraal Bureau voor de Statistiek (CBS, the...

  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Demand
  • Supply
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (EUR Million), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022

Report Description The non residential construction industry in value terms increased at a CAGR of 4.2% during 2013-2017. The commercial building construction market in value terms is expected to record a CAGR of 3.5% over the forecast period. The industrial building construction market in value terms is expected to reach...

  • Commercial Construction
  • Pharmaceutical
  • Netherlands
  • Forecast
  • Market Size
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (EUR Million), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022

Report Description During the review period, value of building construction industry recorded a CAGR of 4.7%. CAGR during the forecast period of 2018 to 2022 is expected to be 5.1%. The residential construction industry in value terms increased at a CAGR of 5.3% during 2013-2017. The commercial building construction market...

  • Commercial Construction
  • Pharmaceutical
  • Netherlands
  • Forecast
  • Market Size
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (EUR Million), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 4.6% to reach US$ 110.1 billion by 2022. The residential construction industry in value terms increased at a CAGR of 5.3% during 2013-2017. The commercial building construction market in value terms is expected to record a CAGR of...

  • Highway And Road Construction
  • Pharmaceutical
  • Netherlands
  • Forecast
  • Market Size
  • NETHERLANDS - OTC MEDICATIONS: COMPANY WEBSITE LINKS
  • NETHERLANDS - OTC MEDICATIONS: COMPANY RETAIL MARKET SHARE BY VALUE (%)

Vemedia Pharma N. V.

  • Pharmaceutical
  • Netherlands
  • Benckiser N.V.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED: REVENUES & PROFITABILITY
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED: ASSETS & LIABILITIES

Introduction Generics in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures...

  • Pharmaceutical
  • Netherlands
  • Mylan Inc.
  • Sandoz Inc.
  • Sanofi S.A.

REFERENCES ##.

  • Allergy Drug
  • Chronic Disease
  • Pharmaceutical
  • Respiratory Disease
  • Netherlands
  • PRICE BUILD UP
  • REIMBURSEMENT

It should be noted that the CG replaced the Pharmaceutical Help Committee (CFH) as of ## January 2013.

  • Health Insurance
  • Hospital
  • Pharmaceutical
  • Netherlands
  • Achmea Group
  • DRIVERS OF SUPPLIER POWER IN THE OTC PHARMACEUTICALS MARKET IN THE NETHERLANDS, 2015
  • SUPPLIER POWER

Exit barriers are fairly high as most companies that manufacture OTC pharmaceuticals are focused on the pharmaceutical market and are similar to one another.

  • Pharmaceutical
  • Netherlands
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • DRIVERS OF DEGREE OF RIVALRY IN THE ORAL HYGIENE MARKET IN THE NETHERLANDS, 2016
  • DEGREE OF RIVALRY

Unilever PLC (Unilever) is one of the largest FMCG companies in the world.

  • Pharmaceutical
  • Netherlands
  • Colgate-Palmolive Company
  • GlaxoSmithKline plc
  • Procter & Gamble Company
  • Kiadis Pharma NV, Pharmaceuticals & Healthcare, Deal Details
  • Kiadis Pharma NV, Subsidiaries

Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders.The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks and limitations...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Netherlands
  • Kiadis Pharma N.V.
  • OMEGA PHARMA NEDERLAND BV IN CONSUMER HEALTH (NETHERLANDS)
  • Passport 12

Vitamins and dietary supplements increased by 3% in current value terms in 2016, to reach €290 million. Vitamins and dietary supplements are becoming increasingly important to the Dutch population. They are seen as an addition to food consumption, and are considered to contribute to a healthy lifestyle. Dutch consumers may not get enough essential...

  • Pharmaceutical
  • Netherlands
  • Demand
  • Pfizer Inc.
  • Vemedia Pharma N.V.
  • HEADLINES
  • COMPETITIVE LANDSCAPE

Passport ## Summary ## Brand name Pikopil OTC: Switches 2016-2017 Manufacturer Vital Pharma GmbH Ingredient/ dosage Natriumpicosulfaat ##, ##ml Switch date March 2016 Source: Euromonitor International from official statistics, trade associations, trade press, trade interviews.

  • OTC
  • Pharmaceutical
  • Netherlands
  • Demand
  • Norgine BV, Key Competitors
  • NORGINE ENTERS INTO DRUG DISCOVERY AGREEMENT WITH JUBILANT

GlobalData Norgine BV' s, deal volume decreased from six pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Netherlands
  • Merus Labs International Inc.

Note: ##.

  • Diabetes
  • Pharmaceutical
  • Netherlands
  • Northern Europe
  • Forecast
  • PROSPECTS

Elderly consumers are regularly taking more than one type of medicine at the same time.

  • OTC
  • Pharmaceutical
  • Netherlands
  • Demand
  • GlaxoSmithKline plc

The company' s deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Pharmaceutical
  • Therapy
  • Netherlands
  • Company
  • Hookipa Biotech AG